|
|
 |
 | Medical News Releases > News Topics > Medical Science >
Cancer
The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is an international leader in patient care, cancer research, prevention, education and community outreach and a National Cancer Institute-designated Cancer Center.
Learn more about the advances in cancer research through the news stories and experts listed below.
| Faculty Experts: |
Showing Cancer Experts 1 through 5 of 21.
- Show More |
|
Matthew Kreuter
Professor
Matt Kreuter is a leading national public health expert in the field of health communications.
Expertise: Health communication, cancer prevention and control, health disparities
Direct contact: 314-935-3701
/
mkreuter@wustl.edu
|
Graham Colditz
Associate Director, Prevention and Control, Siteman Cancer Center
 |
| Colditz |
Dr. Colditz is an Epidemiologist and Associate Director for Prevention and Control at the Alvin J. Siteman Cancer Center, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri. He is the Niess-Gain Family Professor in Medicine, Department of Surgery, at Washington ...
Media assistance: (314) 286-0141 / ericsong@wustl.edu
|
Dione Farria
Assistant Professor of Radiology
Dione Farria is Co-Director for the Alvin J. Siteman Cancer Center Program for the Elimination of Cancer Disparities (PECaD) and an assistant professor of Radiology, Division of Diagnostic Radiology, Section of Breast Imaging. She is certified by the American Board of Radiology and American Board of ...
Expertise: Breast imaging, breast cancer, doctor-patient communication
Media assistance: (314) 286-0141 / ericsong@wustl.edu
|
David Gutmann, M.D., Ph.D.
Donald O. Schnuck Family Professor of Neurology
Gutmann is the founder and director of the Neurofibromatosis Clinical Program, which is dedicated to treating the common inherited tumor predisposition syndrome, neurofibromatosis (NF). Individuals with NF have an increased risk of developing brain tumors and other cancers. As national leader in the ...
Expertise: Brain tumors, cancer genetics, neurofibromatosis, molecular genetics, neurosciences, neurology
Media assistance: (314) 286-0122 / purdym@wustl.edu
|
Michael DeBaun
Professor of Pediatrics, Biostatistics and Neurology
Dr. DeBaun is a professor of pediatrics, biostatistics and neurology and directs the Sickle Cell Medical Treatment and Education Center at St. Louis Children's Hospital. He is board-certified in pediatrics and pediatric hematology/oncology. He received a MPH in epidemiology from The Johns Hopkins University ...
Expertise: overgrowth cancer predisposition syndromes, public health issues, sickle cell disease
Media assistance: (314) 286-0120 / westerhousej@wustl.edu
|
Showing Cancer Experts 1 through 5 of 21.
- Show More |
|
| News Stories & Tip Sheets: |
Showing Cancer Stories 1 through 3 of 238.
- Show More |
|
Saving lives
New treatments improve outlook for pancreatic cancer patients
Oct. 21,
2009 -- A team of surgeons and oncologists at the Siteman Cancer Center at the School of Medicine and Barnes-Jewish Hospital is aggressively tackling pancreatic cancer — one of the deadliest forms of cancer — and conducting clinical trials of innovative treatment regimens.
|
Spoken with feeling
StoryCorps captures stories from cancer survivors and their children
Sept. 28,
2009 --
 |
| Cancer survivor Kathy Ferrara and daughter Natalie continue their dialogue after participating in StoryCorps, a national oral history and research project. |
Cancer is a difficult diagnosis to acknowledge — especially what a parent with can-cer must explain. A StoryCorps project captures the emotional stories of survivors and may help others to say what must be said.
|
Estrogen benefit
Low-dose estrogen shown safe and effective for metastatic breast cancer
Aug. 18,
2009 --
When estrogen-lowering drugs no longer control metastatic breast cancer, the opposite strategy might work. Raising estrogen levels benefited 30 percent of women whose metastatic breast cancer no longer responded to standard anti-estrogen treatment, according to research conducted at the School of Medicine and collaborating institutions.
|
Showing Cancer Stories 1 through 3 of 238.
- Show More |
|
Pancreatic Cancer Deaths Higher for Blacks
U.S. News & World Report online
and 9 others
Sept. 3,
2009 -- Even after eliminating known pancreatic cancer risk factors, such as smoking and obesity, blacks still had a 42 percent higher risk of dying from the disease than their white counterparts, according to a WUSTL-led study, which appears online in Cancer Epidemiology, Biomarkers & Prevention.
|
Meat, Dairy Won't Up Odds for Breast Cancer
U.S. News & World Report online
and 8 others
Aug. 31,
2009 -- For years, dietary factors have been debated as either boosting or reducing the risk of breast cancer, with research yielding conflicting results. But in the new research, scientists could not conclude that meat, eggs or dairy product intake as an adult raised breast cancer risk. Connie Diekman, a registered dietitian and director of university nutrition at WUSTL comments.
|
Take charge of your checkup
MSNBC.com
Aug. 24,
2009 -- Medical tests are no fun, so why take them twice? People often end up with inadvertently skewed results, but some simple prep work will ensure that your numbers are accurate. Includes advice from WUSTL researchers on how not to skew the PSA (prostate cancer screening) exam.
|
Ultra-tiny 'bees' target tumors
CNN International
and 1 others
Aug. 18,
2009 -- Another report on the use of nanobees -- tiny particles designed to destroy cancer cells by delivering a synthesized version of toxin called melittin that is found in bees.
Samuel Wickline, director of WUSTL's Siteman Center of Cancer Nanotechnology Excellence, explains how it works.
Nanobees are one of the latest examples of how nanotechnology may change the way diseases are treated.
|
Genome of Leukemia Patient Reveals Common Mutations
U.S. News & World Report online
and 13 others
Aug. 6,
2009 -- Decoding the genome of a man with acute myeloid leukemia revealed genetic mutations that may be common among other cancer patients. The findings could help scientists understand the genetic basis of cancer. Includes comments by WUSTL researchers Richard Wilson, co-author and director of the Genome Center, and Timothy Ley, study senior author and medicine professor.
|
Affiliated with Barnes-Jewish Hospital and St. Louis Children's Hospital, members of BJC HealthCare.
Please contact us and let us know how we can assist you.
Technical problems with this Web site? Email questions or comments.
Please review the WUSTL News & Information copyright/privacy policy.
| |
|
| | |
|
Download
Show More Cancer Clips
Print ready page